@USPharmacopeiai
iAccount based inUnited States
About this account
- Account based in
- United States
- Connected via
- Web
Account-level information from X, not a live location or the device used for a specific post.
Independent, scientific, non-profit improving #PublicHealth by setting standards for meds, food ingredients & dietary supplements. Retweets not endorsements.
Rockville, MD USA
Joined June 2009
- Tweets12.7K
- Following1.7K
- Followers13.4K
- Likes3K
As biologics get more complex, can quality standards keep pace?
Join GEN and @USPharmacopeia for a free virtual Spotlight on Biologics Standards for Innovation, Quality and Access #cellandgenetherapy #RNA.
Oct 14 | 12:00–2:30 PM ET
Free Register: hubs.li/Q04yzPkq0
USP has launched a new online store that provides a more streamlined experience for users.
The USP Store is a proven, reliable resource of standards and solutions. By introducing improved features and streamlined profile creation, we reflect how teams work in practice, empowering independent, accurate decisions across the ordering and purchasing process.
We want to make it easier for users to move through the platform with clarity and confidence, supporting faster access to standards needed across the product lifecycle.
While the experience has evolved, the trusted standards, solutions, and offerings our users already rely on remain the same.
Explore the new USP Store: usp.org/usp-store-resource-h…
Drug shortages can cause treatment delays, changes to care plans, and higher risk of medication errors, impacting patients and the healthcare professionals who care for them.
While the number of active drug shortages has declined, the vulnerabilities driving them remain, including geographic concentration within the medicine supply chain.
In a new @nabp article, USP Principal Scientist Misti Spann, PharmD, uses USP's latest Annual Drug Shortages Report to show why building medicine supply chain resilience requires looking beyond finished medicines to identify hidden supply risks.
Read more: nabp.pharmacy/news/blog/drug…
USP retweeted
✍️ New Guest Blog Post: "Drug Shortages Decline, but the Medicine Supply Chain Remains Fragile" by Misti Spann, PharmD, Principal Scientist at @USPharmacopeia.
Read the blog post today: 🔗 nabp.me/DrugShortagesBlog
#USP #DrugShortages
Today in managed care: Drug Topics reports that the United States Pharmacopeia’s 2025 Annual Drug Shortages Report shows the total number of drug shortages “dropped for the second year in a row. But the real story is underneath that headline-and it’s the part that matters most to the people doing the work.” While “US drug shortages fell for the second year in a row in 2025 – down 23% to 75 active shortages,” remaining shortages “now last more than 5 years on average, discontinuations hit their highest level since 2019, and for the first time the data exposes how dangerously concentrated the upstream supply chain really is.”
drugtopics.com/view/drug-sho…
USP retweeted
Geographic distribution of #pharmamanufacturing remains driver of U.S. #drugshortages, finds #USPharmacopeia, with 44% of shortage drugs relying on a single country for at least one #KeyStartingMaterial. pharmamanufacturing.com/qual… #pharmaceuticals #India #China #EU #supplychain #FDA
On #EarthDay, learn more about our resolution to help foster more environmental sustainability across the medicines supply chain. USP develops quality testing standards that can help reduce the #EnvironmentalImpact of pharmaceutical manufacturing globally.
USP’s Resolution 5 helps foster more environmental sustainability across the pharmaceutical life cycle – one of seven resolutions adopted by the USP Convention last May to guide USP focus areas for its five-year cycle through 2030.
usp.org/sites/default/files/…
The Drug Shortage Task Force has submitted formal recommendations to @CMSGov regarding its proposed rule on domestic procurement of PPE and essential medicines.
Learn more about the task force on @USPharmacopeia's website: usp.org/supply-chain/drug-sh…
USP retweeted
Unlock reliable IgG4 analysis and discover the new USP mAb-004 Reference Standard in our free GEN webinar, April 21, 2026. Register now: hubs.li/Q049lrYq0 @uspharmacopeia #Biomanufacturing #MonoclonalAntibodies
USP’s Emily Britton, Senior Manager, Market Development for USP’s Verification Programs, was featured on an episode of @Aging_Research 's podcast where she discussed how dietary supplements are regulated and how the USP Verified Mark can serve as a visible quality indicator, helping you choose quality dietary supplement products.
Listen here: ow.ly/erST50YyTbJ
USP retweeted
In Part 2 of this #podcast, #USPharmacopeia CEO Ronald Piervincenzi discusses how to build a more resilient #pharmaceutical #supplychain including domestic capacity for #ActivePharmaceuticalIngredients and #KeyStartingMaterials. pharmamanu.podbean.com/e/fix… #podcasts #supplychains
USP retweeted
The global medicine #supplychain faces chronic #drugshortages, #geopolitical tensions, and #pharmamanufacturing challenges. In this #podcast, Ronald Piervincenzi, CEO of #USPharmacopeia, discusses how to build a more resilient #pharmaceutical supply chain. pharmamanu.podbean.com/e/fix…
New Update from USP! Selected Qualitative Reference Standards (RS) now include a mass balance value in the Additional Information section of the USP Certificate.
Why it matters:
This value, provided for informational purposes only, may support your analytical testing decisions beyond compendial use. Please note that users are responsible for verifying that these standards are suitable for any intended non-compendial uses.
By choosing USP Reference Standards, Documentary Standards, and other products and services, you’re a part of a global cause that aims to ensure access to quality medicines, supplements, and food for over 2 billion people.
Ready to order?
Visit the USP Store: store.usp.org/search?Ntk=pro…
If you have a USP qualitative RS that does not include a value in the USP Certificate and would like one to be included, or if you have any questions, reach out to [email protected]
Yang Liu, Scientific Liaison for General Chapters at USP, was recently featured in an article from @SpectroscopyMag discussing how data-driven methodologies are set to transform spectroscopy in 2026 and beyond. Learn more:
spectroscopyonline.com/view/…
Dans le cadre de notre engagement en faveur de l’élargissement de l'accès à des médicaments de qualité en Afrique, l'USP commencera dès le début 2026 à mettre à disposition une partie de l'USP-NF en français afin de garantir une large accessibilité aux normes de qualité essentielles. Pour en savoir plus: qualitymatters.usp.org/refle…
Des systèmes réglementaires solides et harmonisés sont le fondement de l'avenir pharmaceutique de l'Afrique. Lors de la conférence #SCOMRA2025, @USPharmacopeia a partagé les enseignements tirés de plus de 20 ans d'expérience en matière de collaboration avec les organismes de réglementation afin d'améliorer l'accès à des #QualityMedicines (#médicamentsdequalité) dans toute l'Afrique.
Pour en savoir plus: ow.ly/lA8J50XC9sl
@AfricaPHF @AUDA_Health @NeimatuAdjabui @EmilyKaine1
Since 2018, USP and #Uzbekistan have collaborated to increase access to quality medicines. USP was honored to recently meet with the Minister of Health & Pharmaceutical Industry Development Agency to discuss advancing the reach of trusted medicines to patients. @GOVuz
New USP research shows 58% of KSMs used for US-approved APIs are sole sourced from a single country. Find more data and a policy roadmap for resiliency in our latest blog: bit.ly/4olc9y0
Investment in America’s pharmaceutical security is an investment in our national security. Join our Drug Shortage Task Force webinar to learn how we can address and prevent drug shortages: events.usp.org/en/4164Hr6/dr…
USP has joined the FNIH Biomarkers Consortium, contributing expertise in areas like assay development and validation to advance solutions for new drug development. Learn how this work supports quality throughout the product lifecycle: usp.org/news/usp-joins-fnih-…
We were honored to welcome @mimi_darko to our Rockville office to explore collaborations to support operationalizing the African Medicines Agency (AMA), strengthening regulatory systems, reduce medicine quality risks and strengthen #HealthSecurity. @_AfricanUnion